This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kleinman, S H Articles by Busch, M Search for Related Content PubMed PubMed Citation Articles by Kleinman, S H Articles by Busch, M

Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group.

Southern California Region American Red Cross Blood Services, Los Angeles 90006.

ABSTRACT

Current algorithms for the serologic confirmation of human T-cell lymphotropic virus type I and II (HTLV-I/II) antibody reactivity are complicated. We evaluated the performance of an HTLV-I Western blot (immunoblot) spiked with recombinant p21e protein (p21e WB) as an alternative to current confirmatory methods. These methods include the HTLV-I viral lysate Western blot and either a radioimmunoprecipitation assay or a p21e enzyme-linked immunosorbent assay. Five hundred fifty nine blood donations obtained from five U.S. blood centers and classified as HTLV-I/II seropositive (n = 149) or seroindeterminate (n = 410) by routine testing methods were further evaluated by PCR for proviral DNA and by the p21e WB. On the basis of serologic and PCR testing, 155 donations were classified as HTLV-I/II infected. The sensitivity of the p21e WB was 97.4%, slightly exceeding that of routine confirmatory testing. The specificity of the p21e WB was 97.5%, as determined by testing of 404 seroindeterminate samples that were negative in the PCR. The positive predictive value of the p21e WB was 94%. In contrast, the specificity and positive predictive value of routine confirmatory testing were both 100%. Follow-up sampling of presumptive p21e WB false-positive donors substantiated the absence of HTLV-I/II infection. Although the p21e WB used in this study has high sensitivity and may be useful as a confirmatory assay in epidemiologic research studies, it may not be ideal as a confirmatory test for the notification of blood donors.

This article has been cited by other articles:

• Glynn, S. A., Kleinman, S. H., Schreiber, G. B, Busch, M. P., Wright, D. J., Smith, J. W., Nass, C. C., Williams, A. E., for the Retrovirus Epidemiology Donor Study, (2000). Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996. JAMA 284: 229-235 [Abstract] [Full Text]  
• Sabino, E. C., Zrein, M., Taborda, C. P., Otani, M. M., Ribeiro-Dos-Santos, G., Sáez-Alquézar, A. (1999). Evaluation of the INNO-LIA HTLV I/II Assay for Confirmation of Human T-Cell Leukemia Virus-Reactive Sera in Blood Bank Donations. J. Clin. Microbiol. 37: 1324-1328 [Abstract] [Full Text]  
• Schreiber, G. B., Busch, M. P., Kleinman, S. H., Korelitz, J. J., The Retrovirus Epidemiology Donor Study, (1996). The Risk of Transfusion-Transmitted Viral Infections. NEJM 334: 1685-1690 [Abstract] [Full Text]